Commentary: Management Strategies for POSEIDON Groups 3 and 4

Frontiers in Endocrinology - Switzerland
doi 10.3389/fendo.2020.00034
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA


Related search